Pipeline Watch: 11 Approvals And 12 Phase III Readouts
Executive Summary
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
You may also be interested in...
Sun Backs India-First Stroke Drug From Pharmazz
Sun debuts Pharmazz Inc’s new stroke drug sovateltide in India at under $20/ vial. The selective endothelin-B receptor agonist, which can be administered up to 24 hours post cerebral ischemic stroke, is also being studied in Alzheimer’s disease.
Publisher's Spotlight: Scrip Awards Announces 2023 Finalists
We are delighted to announce the shortlist for the 19th Annual Scrip Awards.
Executives On The Move: 12 New CEOs and 10 New CFOs
Recent executive moves in the industry include new CEOs at Baxter BioPharma Solutions, Destiny Pharma and PAION, while Medicenna Therapeutics, Mirum Pharmaceuticals and Scancell, among others, get new CFOs.